Selective use of adjuvant therapy in the management of Merkel cell carcinoma

JAMA Oncology

Volumn 1, Issue 8, 2015, Pages 1162-1663

  Bichakjian, Christopher K ^a   Harms, Kelly L ^a   Schwartz, Jennifer L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOMA, MERKEL CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; MALE; MORTALITY;

CARCINOMA, MERKEL CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE;

EID: 84965092472     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2015.1503     Document Type: Article

References (6)

1. Breslow A, Macht SD. Optimal size of resection margin for thin cutaneous melanoma. Surg Gynecol Obstet. 1977;145(5):691-692.
2. Tang CK, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer. 1978;42(5): 2311-2321.
3. Bichakjian CK, Olencki T, Alam M, et al; National Comprehensive Cancer Network. Merkel cell carcinoma, version 1.2014. J Natl Compr Canc Netw. 2014;12(3):410-424.
4. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23(10):2300-2309.
5. Schwartz JL, Griffith KA, Lowe L, et al. Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol. 2011;29(8):1036-1041.
6. Erman AB, Collar RM, Griffith KA, et al. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Cancer. 2012;118(4): 1040-1047.